the path to IMPrOVED HEALth FOR WOMEn
Fab Biopharma is developing multiple unique targets against Sjögrens Disease using innovative bispecific soluble receptor fusion protein technology
Our goal is to change the biopharmaceutical industry by creating new biologics for women.
Fab's team has decades of experience in drug development from target discovery to market in biologics and women's health.
Our team has dedicated our careers to women's health including making progress in how diseases are defined, drugs developed and trials executed.
Sign up to hear from us.
Copyright © 2024 Fab Biopharma - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.